In human COPD, lymphocyte inflammation is mainly driven by a Th1 immune response with an enhanced IFN-γ production in both helper (CD4+) and cytotoxic (CD8+) T lymphocytes, that increased with COPD severity [38, 39]. Here, CD4 is linked to chronic obstructive pulmonary disease.